Expanding Health Care Options for First Responders Act
Summary
The Expanding Health Care Options for First Responders Act (S.3221) is an early-stage, unfunded bill that would allow certain retired or disabled first responders aged 50-64 to buy into Medicare. It has been referred to committee with no appropriation mechanism and no near-term market impact. The primary structural beneficiary would be Medicare Advantage insurers like UnitedHealthcare if the bill advances, but passage probability is low given the early stage and absence of funding.
See which stocks are affected
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
Key Takeaways
- 1.S.3221 is an early-stage, unfunded bill with no committee action since introduction in November 2025
- 2.The bill does not appropriate any funds; it creates a self-funded Medicare buy-in option with CMS-set premiums
- 3.Passage probability is low in a divided Congress; no hearings or CBO score have occurred
- 4.If enacted, Medicare Advantage insurers like $UNH, $HUM, and $CVS would be structural beneficiaries through expanded addressable enrollment
Market Implications
No immediate market implications. The bill is in early stage with zero legislative momentum. Investors should not trade on this proposal. It is a procedural introduction by a single senator with no bipartisan co-sponsors. For context, this is standard constituent service legislation that typically does not advance. If the bill were to gain traction — marked by a CBO score, bipartisan co-sponsors, or a hearing — MA insurers would become actionable. As of today, no such catalysts exist.
Full Analysis
-
What happened and status: On November 19, 2025, Senator Ruben Gallego (D-AZ) introduced S.3221, the Expanding Health Care Options for First Responders Act, which was read twice and referred to the Senate Committee on Finance. The bill remains in early stage with no further action. An identical companion bill, HR6147, was introduced in the House and referred to Ways and Means and Energy and Commerce. The bill has not received any hearings, markups, or CBO score.
-
The money trail: The bill authorizes no specific funding amount. It instructs CMS to set premiums for the buy-in option, meaning the program would be self-funded through enrollee premiums. There is no appropriation of federal dollars. This is a critical distinction: the bill creates an eligibility expansion but does not allocate any public spending. Actual federal cost would depend on CBO scoring of premium levels and any subsidy structure, which is not yet available.
-
Structural winners and losers: The primary potential winner is the Medicare Advantage (MA) industry. The bill allows enrollees to choose MA-PD plans (Medicare Advantage with prescription drug coverage). UnitedHealthcare is the largest MA insurer with ~8 million members and ~30% market share. Humana ($HUM) and CVS Health ($CVS, via Aetna) also have significant MA books. However, the bill's impact is highly uncertain because it only creates an option, not a mandate, and premium levels would be set by CMS. If premiums are set attractively, new enrollment could be significant; if set actuarially neutral, uptake may be minimal.
-
Competitive landscape: The bill does not directly benefit any single company through a contract provision. Rather, it expands the total addressable market for Medicare Advantage products to a new population segment. First responders total approximately 4.6 million in the US, but eligibility is limited to those aged 50-64 who are retired or separated due to disability — likely a subset of 1.5-2 million individuals. Current health coverage for this population typically comes from employer-sponsored plans, state health plans, or private insurance. The bill would allow them to switch to Medicare, creating a competitive dynamic between MA insurers and existing employer/private insurers.
-
Timeline: As an early-stage bill in a divided 119th Congress (Republican House majority, Democratic Senate), the path to passage is narrow. The bill must clear the Senate Finance Committee, receive a CBO score, pass the full Senate, clear the House Ways and Means and Energy and Commerce committees, pass the House, and be signed by the President. Given the lack of hearings or bipartisan co-sponsors, this bill is unlikely to become law in this Congress. Market impact is negligible near-term.
Connected Signals
Matched on shared policy language across AI analyses, with ticker & timing weight
Protecting Health Care and Lowering Costs Act of 2025
Association Health Plans Act
To amend title XVIII of the Social Security Act to ensure stability for provider payments under the Medicare program.
Veteran Caregiver Reeducation, Reemployment, and Retirement Act
I CAN Act
Veterans’ ACCESS Act of 2025
Protecting Health Care and Lowering Costs Act
To amend the Employee Retirement Income Security Act of 1974 to ensure that pharmacy benefit managers are considered fiduciaries, and for other purposes.
Related Presidential Actions
Executive orders & memoranda affecting the same sectors or companies
Implementing Schedule Policy/Career in the Excepted Service
This executive order expands the Schedule Policy/Career excepted service category, transferring certain federal positions from competitive service to at-will employment to facilitate removal for poor performance or misconduct. It directs agency heads to petition for reclassification of policy-influencing roles, mandates performance bonus pools for these employees, and amends civil service rules to exempt them from standard adverse action procedures.
Realigning United States Core Childhood Vaccine Recommendations with Best Practices from Peer, Developed Countries
This executive order directs the CDC and ACIP to review and potentially update the U.S. childhood vaccine schedule to align with recommendations from peer developed countries, which recommend fewer vaccines. It maintains insurance coverage for all currently available vaccines without cost sharing and emphasizes protecting religious liberty and parental authority.
Promoting Efficiency, Accountability, and Performance in Federal Contracting
This executive order mandates that federal agencies default to using fixed-price contracts for procurement, shifting away from cost-reimbursement models. It requires written justification and senior-level approval for any non-fixed-price contract over certain dollar thresholds (e.g., $10M for most agencies, $100M for the Department of War), and directs agencies to review and renegotiate their 10 largest non-fixed-price contracts within 90 days. The order also tasks OMB with implementation guidance and the Federal Acquisition Regulatory Council with proposing regulatory amendments within 120 days.